Musculoskeletal Diseases Nervous System Diseases Orthopaedics
Conditions
Interventions
5 mg of amitriptyline.
10 mg Amitriptyline dose
Sponsors
Fayoum University Hospitals
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Presence of CNP for more than 15 days/month during at least three consecutive months. 2. Patients without previous trauma. 3. Patients free from other neurologic disorders except for chronic tension headaches. 4. Age from18 to 75 years. 5. Normal neurologic examination (performed by a neurologist) except for pericranial tenderness. 6. No imaging abnormalities except for a loss of cervical lordosis.
Exclusion criteria
Exclusion criteria: 1. The presence of neurologic disorder revealed an abnormal clinical examination. 2. Abnormal imaging or history of cervical disc disease. 3. Migraine headache. 4. History of trauma. 5. Major depressive disorder. 6. Analgesic abuse. 7. History of intolerance to tricyclic or tetracyclic antidepressants. 8. Current psychiatric disorder. 9. Glaucoma, cardiac rhythm abnormalities, severe constipation. 10. Patients on medications for CNP other than NSAID or paracetamol taken during the last month. 11. Pregnancy in women and prostatic symptoms in men.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neck Pain Disability Index. NPDI | — |
Secondary
| Measure | Time frame |
|---|---|
| Neck pain intensity;Athens Insomnia Scale;Anxiety and depressive symptoms will be evaluated with Hospital Anxiety and Depression Scale (HADS), | — |
Countries
Egypt
Contacts
Public ContactAtef Khaleel.
Lecturer of Anesthesiology Fayoum University
Outcome results
None listed